|
|
|
Feed Submission If you'd like OHCNetwork Health News to link to your health news or blog from this category (Crohns - Digestion - Diseases and Conditions), please submit your RSS or XML feed to OHCNetwork Health News. Contact information is available here. |
Health News >> Diseases and Conditions >> Digestion >> Crohns
Crohns News
Crohn's News From Medical News Today
The University of Alabama at Birmingham (UAB) Center for Education and Research on Therapeutics (CERTs) has won a $2.2 million federal grant to study the risks and benefits of a newer class of medicines called biologics. These are genetically engineered therapies that target the immune system of patients who have rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders.
Crohn's News From Medical News Today
Thousands of Americans suffering from the chronic inflammatory bowel condition known as Crohn's disease are leading longer, healthier lives due to innovative new surgeries, according to experts at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Crohn's News From Medical News Today
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced new findings regarding the correlation between serologic markers and the diagnostic predictions of children with Crohn's disease following an analysis of PROMETHEUS(R) IBD Serology 7 test results.
Crohn's News From Medical News Today
Additional study shows further research needed on 5-ASA's chemopreventative role in ulcerative colitis Inflammatory bowel disease (IBD) is a term that refers to both ulcerative colitis (UC) and Crohn's disease (CD). IBD occurs most frequently in people in their late teens and twenties. There have been cases in children as young as two years old and in older adults in their seventies and eighties; men and women have an equal chance of getting the disease.
Crohn's News From Medical News Today
Researchers in Spain and the United Kingdom are reporting development of a faster test for identifying the food protein that triggers celiac disease, a difficult-to-diagnose digestive disease involving the inability to digest protein called gluten that occurs in wheat, oats, rye, and barley. The finding could help millions of people avoid diarrhea, bloating, and other symptoms that occur when they unknowingly eat foods containing gluten.
Crohn's News From Medical News Today
At this week's opening of the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition (Atlanta, USA, November 16-20, 2008) Philips Research will announce its new intelligent pill technology "iPill", targeted at assisting drug development and enabling new therapies for debilitating and life-threatening digestive tract disorders such as Crohn's disease, colitis and colon cancer.
Crohn's News From Medical News Today
New data showed that Abbott's (NYSE: ABT) HUMIRA® (adalimumab) provided long-term treatment of fistulas, with more than half of patients with moderate to severe Crohn's disease experiencing fistula healing at three years, according to clinical research presented today at the United European Gastroenterology Week (UEGW) congress in Vienna.
Crohn's News From Medical News Today
The tonsils and lymphoid tissues in the intestinal tract that help protect the body from external pathogens are the home base of a rare immune cell newly identified by researchers at Washington University School of Medicine in St. Louis. The researchers indicate that the immune cells could have a therapeutic role in inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis.
Crohn's News From Medical News Today
Neovacs, a leading biotechnology company in the development of anti-cytokine and anti-protein viral regulation therapeutic vaccines to treat certain cancers and inflammatory diseases, announced that it had begun a phase I/II clinical study at three study centres in South Africa with the candidate TNFα-kinoid, a therapeutic vaccine for the treatment of TNFα dependent auto-immune diseases such as rheumatoid arthritis, Crohn's disease and psoriasis.
Crohn's News From Medical News Today
Data presented today at the United European Gastroenterology Week Congress (UEGW) show that a significantly greater proportion of patients with moderate to severe Crohn's disease experienced steroid-free remission and mucosal healing when receiving Remicade(R) (infliximab), either in combination with azathioprine or as monotherapy, compared to patients receiving azathioprine alone.
Crohn's News From Medical News Today
New data showed that Abbott's HUMIRA® (adalimumab) provided long-term treatment of fistulas, with more than half of patients with moderate to severe Crohn's disease experiencing fistula healing at three years, according to clinical research presented today at the United European Gastroenterology Week (UEGW) congress in Vienna.
Crohn's News From Medical News Today
To help those with inflammatory bowel disease (IBD) be better informed and involved in managing their disease, the European Foundation of Crohn's & Ulcerative Colitis Associations (EFCCA) has launched a new series of guides titled "Life and IBD". For over one million people across Europe who have it, IBD can be an overwhelming experience with new physicians, medications and terminology.
Crohn's News From Medical News Today
Data from two studies presented this week by UCB at the American College of Gastroenterology (ACG) Annual Meeting demonstrate that CIMZIA(R) (certolizumab pegol) - the only PEGylated anti-TNF alpha (Tumor Necrosis Factor alpha) - provides sustained improvement in symptoms with stable dosing for adult patients suffering from moderate to severe Crohn's disease (CD).
Crohn's News From Medical News Today
A study led by Mayo Clinic has found that infliximab (Remicade®) administered alone (monotherapy) or in combination with azathioprine is a more effective treatment for patients with moderate to severe Crohn's disease than azathioprine alone. These findings were presented at the 2008 American College of Gastroenterology (ACG) Annual Meeting. Crohn's disease is an inflammatory disorder of the gastrointestinal tract that affects an estimated 500,000 people in the United States.
Crohn's News From Medical News Today
UCB presented data from a large, prospective study investigating endoscopic improvement in Crohn's disease (CD) with a biologic compound.
Crohn's News From Medical News Today
Data presented for the first time from the Phase 3b Study of Patients with Crohn's Disease Naive to Immunomodulators and Biologic Therapy (SONIC) may provide new insights into the approach to care of patients with moderate to severe Crohn's disease.
Crohn's News From Medical News Today
Scientists report online in Nature that they have linked the health of specialized gut immune cells to a gene associated with Crohn's disease, an often debilitating and increasingly prevalent inflammatory bowel disorder. The link to immune cells intrigued researchers at Washington University School of Medicine in St. Louis because they and others believe Crohn's disease is caused by misdirected immune responses in the intestine that damage gut tissue.
Crohn's News From Medical News Today
Ore Pharmaceuticals Inc. (NASDAQ: ORXE) announced today that it has initiated dosing subjects with GL1001, the Company's lead drug candidate, in a multiple ascending dose clinical trial. GL1001, the first clinical-stage inhibitor of the ACE2 enzyme, is an orally administered small molecule that has decreased several disease activity measures in in vivo models of inflammatory bowel disease (IBD) and gastritis.
Crohn's News From Medical News Today
The Philadelphia Inquirer on Tuesday -- in the second article of a series titled "Falling Through: Casualties of the Health Insurance Crisis" -- examined how people with chronic illnesses face challenges in obtaining affordable health coverage.
Crohn's News From Medical News Today
Neuroendocrine tumors, such as carcinoid tumors, overexpress somatostatin receptors in their membranes. Octreotide is an analogue whose molecule is a shortened version of somatostatin's with a high affinity for these receptors. The labelled form of octreotide is able to be imaged in scans (Octreoscan) and, therefore, pathological conditions overexpressing somatostatin receptors are easily recognized in this technique.
Crohn's News From Medical News Today
A study of Crohn's disease and ulcerative colitis in children has identified a gene that influences whether children get these diseases early in life, and points to a potential new target for treatment. The findings of the international team that performed the study were published online this week by the journal Nature Genetics.
Crohn's News From Medical News Today
Cardiff has the highest incidence of Crohn's Disease in the UK. The University Hospital of Wales is conducting research into the condition with eminent gastroenterologist Dr Hawthorne of Cardiff and Vale NHS Trust who himself is part of a national study. Researchers are analysing data from the last 25 years in an attempt to explain what could cause the condition to be more prevalent in Cardiff isolating such factors as diet, bacterial infection and genetic impact.
Crohn's News From Medical News Today
People with Crohn's disease (CD) are seven-fold more likely to have in their gut tissues the bacterium that causes a digestive-tract disease in cattle called Johne's disease. The role this bacterium may or may not play in causing CD is a top research priority, according to a new report released by the American Academy of Microbiology.
Crohn's News From Medical News Today
According to a study released on July 9, 2008 in the Journal of Pediatric Gastroenterology and Nutrition, PillCam capsule endoscopy in the small intestines may improve Crohn's Disease treatment regimens in children by assisting in appropriate classification of inflammatory bowel diseases. Inflammatory bowel diseases (IBD) are a set of chronic inflammatory diseases of the intestinal tract.
Crohn's News From Medical News Today
Physician-scientists from NewYork-Presbyterian/Weill Cornell, involved in clinical trials for a new drug for those who suffer from inflammatory bowel disease (IBD), say it is the best option among available drugs. Gaizo is a reformulation of the active ingredient 5-ASA in currently available drugs. However, the researchers found that 99 percent of the active ingredient in the new pill is released in the colon compared to only 70 percent in other common IBD drugs. Dr.
MedicineNet Digestion General
Title: Health Tip: Are You Anemic?
Category: Health News
Created: 12/4/2008 2:00:00 AM
Last Editorial Review: 12/4/2008
Category: Health News
Created: 12/4/2008 2:00:00 AM
Last Editorial Review: 12/4/2008
MedicineNet Digestion General
Title: Liver Blood Tests
Category: Procedures and Tests
Created: 6/2/1998
Last Editorial Review: 12/2/2008
Category: Procedures and Tests
Created: 6/2/1998
Last Editorial Review: 12/2/2008
MedicineNet Digestion General
Title: FDA Touts Efforts to Enhance Food Safety
Category: Health News
Created: 12/2/2008 2:00:00 AM
Last Editorial Review: 12/2/2008
Category: Health News
Created: 12/2/2008 2:00:00 AM
Last Editorial Review: 12/2/2008
MedicineNet Digestion General
Title: Urinary Tract Infection (UTI) Symptoms
Category: Doctor's Views
Created: 12/2/2008
Last Editorial Review: 12/2/2008
Category: Doctor's Views
Created: 12/2/2008
Last Editorial Review: 12/2/2008
MedicineNet Digestion General
Title: Obesity
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 12/1/2008
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 12/1/2008
MedicineNet Digestion General
Title: Transfusing Anemic Cancer Patients Boosts Clot Risk
Category: Health News
Created: 11/29/2008 2:00:00 AM
Last Editorial Review: 12/1/2008
Category: Health News
Created: 11/29/2008 2:00:00 AM
Last Editorial Review: 12/1/2008
MedicineNet Digestion General
Title: FAQ: Melamine in U.S. Baby Formula
Category: Health News
Created: 12/1/2008
Last Editorial Review: 12/1/2008
Category: Health News
Created: 12/1/2008
Last Editorial Review: 12/1/2008
MedicineNet Digestion General
Title: cefdinir, Omnicef
Category: Medications
Created: 2/6/2000 8:44:00 PM
Last Editorial Review: 11/26/2008
Category: Medications
Created: 2/6/2000 8:44:00 PM
Last Editorial Review: 11/26/2008
MedicineNet Digestion General
Title: 'Off-Label' Drug Use Is Common
Category: Health News
Created: 11/25/2008
Last Editorial Review: 11/25/2008
Category: Health News
Created: 11/25/2008
Last Editorial Review: 11/25/2008
MedicineNet Digestion General
Title: New Gout Drug Gets FDA Panel Nod
Category: Health News
Created: 11/25/2008
Last Editorial Review: 11/25/2008
Category: Health News
Created: 11/25/2008
Last Editorial Review: 11/25/2008
MedicineNet Digestion General
Title: Eustachian Tube Problems (Problems Clearing Your Ears)
Category: Diseases and Conditions
Created: 5/29/1999 9:47:00 AM
Last Editorial Review: 11/24/2008
Category: Diseases and Conditions
Created: 5/29/1999 9:47:00 AM
Last Editorial Review: 11/24/2008
MedicineNet Digestion General
Title: Health Tip: Signs of Celiac Disease in Children
Category: Health News
Created: 11/22/2008 2:00:00 AM
Last Editorial Review: 11/24/2008
Category: Health News
Created: 11/22/2008 2:00:00 AM
Last Editorial Review: 11/24/2008
| ||||||||||||||||||
| ||||||||||||||||||